The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluation of disease-free survival as surrogate endpoint for overall survival using two individual patient data meta-analyses of adjuvant chemotherapy in operable non-small cell lung cancer.
S. Michiels
No relevant relationships to disclose
A. Mauguen
No relevant relationships to disclose
D. Fisher
No relevant relationships to disclose
S. Burdett
No relevant relationships to disclose
R. Paulus
No relevant relationships to disclose
S. J. Mandrekar
No relevant relationships to disclose
C. P. Belani
No relevant relationships to disclose
F. A. Shepherd
No relevant relationships to disclose
T. Eisen
No relevant relationships to disclose
H. Pang
No relevant relationships to disclose
L. Collette
No relevant relationships to disclose
C. Le Pechoux
No relevant relationships to disclose
J. Pignon
No relevant relationships to disclose